Buy Wegovy online in Australia from Onlinepharmaustralia. Wegovy treatment timeline in Australia is a prescription medicine containing semaglutide that is administered once weekly. For eligible adults using Wegovy for chronic weight management, treatment normally follows a gradual dose-escalation process before reaching the usual maintenance dose.
Understanding the Wegovy treatment timeline can help patients understand what happens during the first few weeks, when the dose normally increases, when the maintenance phase begins, and why treatment may be adjusted according to individual tolerability.
In Australia, Wegovy is registered for chronic weight management in eligible adults alongside a reduced-energy diet and increased physical activity. It is a Schedule 4 prescription medicine.
What Is the Wegovy Treatment Timeline?
The Wegovy treatment timeline describes the different stages of treatment from the initial injection through dose escalation and ongoing maintenance.
For the standard adult weight-management schedule, the Australian Product Information describes the following progression:
| Treatment period | Weekly Wegovy dose | Treatment stage |
|---|---|---|
| Weeks 1–4 | 0.25 mg | Starting phase |
| Weeks 5–8 | 0.5 mg | First escalation |
| Weeks 9–12 | 1 mg | Further escalation |
| Weeks 13–16 | 1.7 mg | Final escalation |
| After week 16 | 2.4 mg | Usual maintenance dose |
The standard maintenance dose of 2.4 mg once weekly is reached gradually over the first 16 weeks.
This is a general treatment framework. Your healthcare professional may adjust the timeline according to your medical circumstances and how well you tolerate treatment.
Wegovy Treatment Timeline: Before Starting
Medical Assessment
Before receiving Wegovy, an appropriate healthcare professional should assess whether treatment is suitable.
For adult chronic weight management, the Australian indication includes people with an initial BMI of:
- 30 kg/m² or higher, or
- 27 kg/m² to less than 30 kg/m² with at least one weight-related comorbidity.
Wegovy is used alongside dietary and physical-activity measures.
A medical assessment may also consider:
- Medical history
- Current medicines
- Previous weight-management treatments
- Existing health conditions
- Treatment goals
- Potential contraindications or precautions
- Pregnancy or pregnancy plans
- Previous medication reactions
Meeting a BMI threshold does not automatically mean Wegovy is appropriate. The prescribing decision should be based on the individual’s broader clinical circumstances.
Weeks 1–4: Starting Wegovy
0.25 mg Once Weekly
The first stage of the standard Wegovy timeline is 0.25 mg once weekly for four weeks.
This is the starting dose rather than the usual maintenance dose.
The purpose of starting at a lower dose is to allow the body to adjust gradually to semaglutide.
During this stage, some patients may notice gastrointestinal symptoms such as nausea, vomiting, diarrhoea or constipation.
Not everyone experiences the same effects, and individual responses can vary.
Do not increase the dose early simply because you want faster results.
What Should You Expect During the First Month?
The first month is primarily an adjustment period.
You are learning how to:
- Administer your weekly injection
- Remember your injection day
- Follow your prescribed dose
- Store your medicine correctly
- Recognise possible side effects
- Incorporate treatment into your normal routine
Your healthcare professional may also want to know how you are tolerating the medicine before the next dose increase.
It is important not to judge the entire treatment based only on the first few weeks.
Weeks 5–8: First Dose Increase
0.5 mg Once Weekly
During weeks 5 through 8, the standard schedule increases to 0.5 mg once weekly.
This is the first dose-escalation stage.
The increase is designed to occur gradually rather than moving immediately to the maintenance dose.
If significant gastrointestinal symptoms occur, speak with your healthcare professional before progressing to the next stage.
The Australian Product Information allows dose escalation to be delayed when significant gastrointestinal symptoms occur.
Weeks 9–12: Further Dose Escalation
1 mg Once Weekly
During weeks 9 through 12, the standard dose increases to 1 mg once weekly.
At this point, treatment is still within the dose-escalation phase.
Your healthcare professional can assess:
- Tolerability
- Side effects
- Treatment response
- Other medicines
- Any changes in your health
The dose should not be increased faster than prescribed.
Weeks 13–16: Final Standard Escalation
1.7 mg Once Weekly
During weeks 13 through 16, the standard dose increases to 1.7 mg once weekly.
This is the final standard escalation stage before the usual adult maintenance dose.
If the patient is experiencing significant gastrointestinal symptoms, the treatment timeline may need to be adjusted.
A slower progression is sometimes more appropriate than forcing the treatment to follow a calendar.
After Week 16: Maintenance Phase
2.4 mg Once Weekly
After the standard escalation period, the usual adult maintenance dose is 2.4 mg once weekly.
The maintenance phase is the ongoing stage of treatment.
Wegovy is approved in Australia for chronic weight management, including both weight loss and weight maintenance, in eligible adults.
There is no universal date on which treatment must end. The appropriate duration depends on individual circumstances and ongoing medical assessment.
Can the Wegovy Timeline Be Slower?
Yes.
The standard 16-week schedule should not be treated as a requirement that every patient must follow regardless of side effects.
If significant gastrointestinal symptoms occur, the Australian Product Information allows dose escalation to be delayed until symptoms improve.
If the 2.4 mg maintenance dose is not tolerated, the dose may temporarily be reduced to 1.7 mg once weekly, with an attempt to return to the recommended maintenance dose later.
These adjustments should be made by a healthcare professional.
Does Everyone Experience Weight Loss at the Same Time?
No.
The Wegovy treatment timeline describes medication dosing, not a guaranteed weight-loss timeline.
Individual responses vary.
Some people may notice changes in appetite or eating patterns relatively early, while measurable changes in body weight may take longer.
The amount and rate of weight change cannot be predicted for an individual simply by looking at the dose schedule.
Wegovy is intended to be used alongside appropriate dietary and physical-activity measures.
What Happens During the Maintenance Phase?
The maintenance phase is not simply a point at which treatment stops being monitored.
Ongoing care may include assessment of:
- Body weight
- Treatment response
- Side effects
- Dose tolerance
- Dietary habits
- Physical activity
- Other medicines
- Existing health conditions
- Long-term treatment goals
The purpose is to determine whether the treatment remains appropriate and well tolerated.
Wegovy Treatment Timeline and Side Effects
Side effects can occur at different stages of treatment, but gastrointestinal effects are particularly relevant during dose escalation.
Potential symptoms include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
- Indigestion
If symptoms are severe, persistent or concerning, contact your healthcare professional.
The TGA has also issued updated safety information for GLP-1 receptor agonists, including semaglutide, concerning a rare eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION).
Any sudden or significant change in vision should receive prompt medical attention.
Wegovy Treatment Timeline and Missed Doses
Missing an injection does not mean that you should automatically take an extra dose.
The Australian Product Information states that if a missed dose is within 5 days, it should be administered as soon as possible.
If more than 5 days have passed, the missed dose should be skipped and the next dose taken on the normal scheduled day.
If multiple doses have been missed, your healthcare professional may consider whether treatment should be restarted at a lower dose.
Can You Change Your Weekly Wegovy Injection Day?
Yes.
Wegovy is administered once weekly, and the injection can be taken at any time of day, with or without meals.
When changing the weekly administration day, the Australian Product Information specifies that there should be at least 72 hours between two doses.
After changing the day, continue with the new weekly schedule.
Wegovy Treatment Timeline and Injection Sites
Wegovy is administered by subcutaneous injection.
The Australian Product Information identifies the:
- Abdomen
- Thigh
- Upper arm
as appropriate injection sites.
Wegovy should not be injected into a vein or muscle.
If you are unsure how to use your particular device, ask your pharmacist or healthcare professional for instructions.
Wegovy Treatment Timeline and Storage
Correct storage is important throughout treatment.
Healthdirect currently states that Wegovy should be:
- Stored at 2°C to 8°C
- Protected from light
- Not frozen
Always follow the storage instructions supplied with your specific product.
If you believe your medicine has been frozen or stored incorrectly, speak with a pharmacist before using it.
What Happens After Several Months of Wegovy?
Once the initial escalation period has finished, treatment generally moves into the maintenance phase.
At this point, the focus shifts from increasing the dose to maintaining an appropriate treatment plan and monitoring the patient’s response.
A healthcare professional may review whether:
- The current dose is tolerated
- Treatment goals are being met
- Side effects remain manageable
- Lifestyle measures are being maintained
- Other medicines have changed
- The treatment should continue
Wegovy is intended for chronic weight management, so treatment can extend beyond the initial 16-week escalation period when clinically appropriate.
What Happens If You Stop Wegovy?
The decision to stop treatment should be discussed with your healthcare professional.
There is no universal stopping date that applies to every patient.
Because Wegovy is used for chronic weight management, the decision to continue or discontinue treatment should consider the individual’s response, treatment goals, tolerability and overall medical circumstances.
Do not change or stop prescription treatment without discussing it with your prescriber.
Wegovy Treatment Timeline: Month-by-Month Overview
A simple overview of the standard adult schedule is:
Month 1 — Weeks 1–4
0.25 mg once weekly
Starting and adjustment phase.
2 — Weeks 5–8
0.5 mg once weekly
First standard dose increase.
3 — Weeks 9–12
1 mg once weekly
Continued dose escalation.
4 — Weeks 13–16
1.7 mg once weekly
Final standard escalation stage.
after month 4
2.4 mg once weekly
Usual adult maintenance phase.
This is a general Australian dosing framework, not an individualized treatment prescription.
Wegovy Treatment Timeline vs Wegovy Treatment Schedule
These two topics overlap, but they serve different search intents.
Wegovy treatment schedule focuses primarily on the dosing plan:
- 0.25 mg
- 0.5 mg
- 1 mg
- 1.7 mg
- 2.4 mg
Wegovy treatment timeline is broader.
It explains what happens across the treatment journey, including:
- Before starting
- First month
- Dose escalation
- Maintenance
- Monitoring
- Missed doses
- Side effects
- Long-term treatment
This makes the timeline article particularly useful for patients researching what treatment may look like over time.
Frequently Asked Questions About the Wegovy Treatment Timeline
How long does the Wegovy treatment timeline take before reaching 2.4 mg?
Under the standard adult schedule, dose escalation takes approximately 16 weeks before reaching the usual 2.4 mg maintenance dose.
What happens during the first month of Wegovy?
The standard starting dose is 0.25 mg once weekly for weeks 1–4. This is the initial adjustment phase.
When does Wegovy start increasing in dose?
Under the standard schedule, the dose increases after each four-week period, progressing from 0.25 mg to 0.5 mg, then 1 mg and 1.7 mg.
When do you reach the Wegovy maintenance dose?
The usual adult maintenance dose of 2.4 mg once weekly is reached after the standard 16-week escalation period.
Can the Wegovy treatment timeline be extended?
Yes. If significant gastrointestinal symptoms occur, dose escalation may be delayed. Treatment should be adjusted according to individual tolerability and medical advice.
How long do you stay on Wegovy?
There is no single treatment duration for everyone. Wegovy is approved for chronic weight management, including weight maintenance, so treatment may continue when clinically appropriate.
How quickly should I expect weight loss from Wegovy?
There is no guaranteed individual weight-loss timeline. Response varies between patients, and treatment should be assessed alongside dietary and physical-activity measures.
What happens if I miss a Wegovy dose during the timeline?
If the missed dose is within 5 days, take it as soon as possible. If more than 5 days have passed, skip it and take the next dose on the normal scheduled day.
Can I increase Wegovy faster than the standard timeline?
Do not accelerate the dose-escalation schedule yourself. Faster increases can affect tolerability, and dose changes should be directed by your healthcare professional.
Does everyone reach 2.4 mg?
The standard adult schedule progresses toward 2.4 mg, but treatment can be adjusted if that dose is not tolerated.
Is Wegovy available by prescription in Australia?
Yes. Healthdirect lists Wegovy as a Schedule 4 prescription-only medicine supplied through a pharmacist with a prescription.
Final Thoughts
The Wegovy treatment timeline provides a useful way to understand how semaglutide treatment progresses over time.
For the standard adult weight-management schedule in Australia, treatment begins at 0.25 mg once weekly, progresses through 0.5 mg, 1 mg and 1.7 mg during the first 16 weeks, and then reaches the usual 2.4 mg once-weekly maintenance dose.
However, this timeline is a general framework rather than a fixed prescription for every patient. Dose escalation can be delayed when significant gastrointestinal symptoms occur, and treatment can be adjusted according to individual tolerability.
If you are considering Wegovy or have already started treatment, discuss your individual timeline with your doctor or pharmacist and follow the current Australian Product Information supplied with your medicine.
Medical Information Notice: This article is for general educational purposes and does not replace individual medical advice, diagnosis or treatment. Wegovy is a prescription medicine. Always follow your prescriber’s instructions and the current Australian Product Information and Consumer Medicine Information. Medicine information can change as new evidence and safety information become available.